Symbol Lookup

Tuesday May 26, 2015 11:28 PM ET. Data delayed 15 minutes.
-0.01 (-16.45%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
No documents available

Company Information

CardioGenics Holdings Inc. is a Canada-based development-stage company. The Company develops technology and products targeting the immunoassay segment of the in vitro diagnostic (IVD) testing market. The Company‚Äôs products include: QL Care Analyzer (QLCA), Cardiovascular Tests and Paramagnetic Beads.  The QLCA represents a shift in the design of point-of-care (POC) analyzers. To support the use of the QLCA, the Company has developed four immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack. These tests include Troponin I (TnI), Plasminogen Activator Inhibitor Type-1 (PAI-1), Heart Failure Risk Stratification (HFRS) and Heart Failure Genomics Risk (HFGR).  Pramagnetic (magnetic) beads are the common solid phase employed during immunoassays tests in these laboratories. The Company has developed a process that coats the beads with a layer of silver, making them white and more sensitive to light.


Headquarters6865 SW 18th St Ste B13
BOCA RATON, FL, United States 33433-7057


Acting Independent Chairman of the BoardJ.Neil Tabatznik
Chief Executive Officer, DirectorYahia Gawad
Chief Financial OfficerJames Essex
Corporate Secretary, DirectorLinda Sterling
Independent DirectorKarim Murabet

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$2.5MBeta1.50
Revenue (TTM)$0.00EPS$-0.05
Shares Out.63.3MBook Value$-0.02
CardioGenics Holdings Inc does not pay a dividend.P/E--
Price/Sales (TTM)--
P/Cash Flow (TTM)--
Operating Margin--

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample